| Pharmaceuticals Industry | Healthcare Sector | Mr. Hai-Ryong Park CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 19 Apr 2006 Last Split | - IPO Date |
Korean Drug Co., Ltd., founded in 1980 and based in Seoul, South Korea, stands at the forefront of pharmaceutical manufacturing and distribution. Dedicated to the development and provision of a wide range of therapeutic solutions, the company has established itself as a key player in the South Korean pharmaceutical industry. With a focus on innovation and quality, Korean Drug Co., Ltd. caters to diverse medical needs, aiming to improve patient health and well-being through effective medicinal products. Over the years, its commitment to excellence and continuous research has enabled it to offer advanced treatment options for a variety of diseases, solidifying its reputation within the healthcare sector.
Korean Drug Co., Ltd. prides itself on an extensive portfolio of medicinal products designed to address a broad spectrum of health conditions. Each product reflects the company’s dedication to quality, safety, and efficacy. Below is an overview of their key offerings: